MedTrace Logo

Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease

NCT06998316 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2025-05-31

No results posted yet for this study

Summary

The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease.

DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic consultation, for a potential rheumatologic inflammatory disease.

The investigators will translate the 2 questionnaire in french thanks to an external translation company, from english to french, then back to english to make sure the translation is correct.

Then, the main question is:

is there a conceptual and semantic equivalence beetween the original english questionnaire and the french-translated one.

Participant will answer the 2 screening questionnaire, one initial time during a consultation, and a second time after 1 month.

Conditions

  • Spondylarthritis
  • Inflammatory Bowel Diseases
  • Crohn Disease
  • Ulcerative Colitis
  • Spondylitis, Ankylosing

Interventions

OTHER

Screening questionnaire

Every patient will answer the 2 screening questionnaires given to them, once at baseline and a second time after 1 month.

Sponsors & Collaborators

  • Clinique des Cèdres, Echirolles

    collaborator UNKNOWN

  • University Hospital, Grenoble

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2026-04-30
Completion
2026-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06998316 on ClinicalTrials.gov